Risk Factors for Symptom Relapse in Collagenous Colitis After Withdrawal of Short-term Budesonide Therapy

Stephan Miehlke; Jesper B Hansen; Ahmed Madisch; Franca Schwarz; Eberhard Kuhlisch; Andrea Morgner; Peter S Teglbjaerg; Michael Vieth; Daniela Aust; Ole K Bonderup

doi:10.1097/01.MIB.0000438135.88681.98

Risk Factors for Symptom Relapse in Collagenous Colitis After Withdrawal of Short-term Budesonide Therapy

Stephan Miehlke, Jesper B Hansen, Ahmed Madisch, Franca Schwarz, Eberhard Kuhlisch, Andrea Morgner, Peter S Teglbjaerg, Michael Vieth, Daniela Aust, Ole K Bonderup

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

24 Citationer (Scopus)

Abstract

Oral budesonide has been proven effective in short- and long-term treatment of collagenous colitis; however, symptom relapse frequently occurs after drug withdrawal. The aim of this study was to identify the risk factors for symptom relapse in patients with collagenous colitis after withdrawal of short-term budesonide therapy.

Originalsprog	Engelsk
Tidsskrift	Inflammatory Bowel Diseases
Vol/bind	19
Udgave nummer	13
Sider (fra-til)	2763-7
Antal sider	5
ISSN	1078-0998
DOI	https://doi.org/10.1097/01.MIB.0000438135.88681.98
Status	Udgivet - dec. 2013

Adgang til dokumentet

10.1097/01.MIB.0000438135.88681.98

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

@article{5ce6ba8d90b3436a88e93a749bfe6011,

title = "Risk Factors for Symptom Relapse in Collagenous Colitis After Withdrawal of Short-term Budesonide Therapy",

abstract = "Oral budesonide has been proven effective in short- and long-term treatment of collagenous colitis; however, symptom relapse frequently occurs after drug withdrawal. The aim of this study was to identify the risk factors for symptom relapse in patients with collagenous colitis after withdrawal of short-term budesonide therapy.",

author = "Stephan Miehlke and Hansen, {Jesper B} and Ahmed Madisch and Franca Schwarz and Eberhard Kuhlisch and Andrea Morgner and Teglbjaerg, {Peter S} and Michael Vieth and Daniela Aust and Bonderup, {Ole K}",

year = "2013",

month = dec,

doi = "10.1097/01.MIB.0000438135.88681.98",

language = "English",

volume = "19",

pages = "2763--7",

journal = "Inflammatory Bowel Diseases",

issn = "1078-0998",

publisher = "Lippincott Williams & Wilkins",

number = "13",

}

TY - JOUR

T1 - Risk Factors for Symptom Relapse in Collagenous Colitis After Withdrawal of Short-term Budesonide Therapy

AU - Miehlke, Stephan

AU - Hansen, Jesper B

AU - Madisch, Ahmed

AU - Schwarz, Franca

AU - Kuhlisch, Eberhard

AU - Morgner, Andrea

AU - Teglbjaerg, Peter S

AU - Vieth, Michael

AU - Aust, Daniela

AU - Bonderup, Ole K

PY - 2013/12

Y1 - 2013/12

N2 - Oral budesonide has been proven effective in short- and long-term treatment of collagenous colitis; however, symptom relapse frequently occurs after drug withdrawal. The aim of this study was to identify the risk factors for symptom relapse in patients with collagenous colitis after withdrawal of short-term budesonide therapy.

AB - Oral budesonide has been proven effective in short- and long-term treatment of collagenous colitis; however, symptom relapse frequently occurs after drug withdrawal. The aim of this study was to identify the risk factors for symptom relapse in patients with collagenous colitis after withdrawal of short-term budesonide therapy.

U2 - 10.1097/01.MIB.0000438135.88681.98

DO - 10.1097/01.MIB.0000438135.88681.98

M3 - Journal article

C2 - 24216688

SN - 1078-0998

VL - 19

SP - 2763

EP - 2767

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

IS - 13

ER -

Risk Factors for Symptom Relapse in Collagenous Colitis After Withdrawal of Short-term Budesonide Therapy

Abstract

Adgang til dokumentet

AUB Link

Fingeraftryk

Citationsformater